These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 7910135)
1. Immunohistochemical analysis of p53 oncoprotein and proliferating cell nuclear antigen (PCNA) in the cervix uteri. Cardillo MR; Stamp GW; Pignatelli MN; Lalani EN Eur J Gynaecol Oncol; 1993; 14(6):484-90. PubMed ID: 7910135 [TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical detection of p53 in cervical epithelial lesions with or without infection of human papillomavirus types 16 and 18. Akasofu M; Oda Y Virchows Arch; 1995; 425(6):593-602. PubMed ID: 7697216 [TBL] [Abstract][Full Text] [Related]
3. The association of vascular proliferation with HPV status and epithelial PCNA positivity in cervical intraepithelial lesions. Soini Y; Pöllänen R; Kemppainen S; Pääkkö P; Lehto VP APMIS; 1996 Mar; 104(3):183-90. PubMed ID: 8611192 [TBL] [Abstract][Full Text] [Related]
4. p53 immunoreactivity in cervical intraepithelial neoplasia and non-neoplastic cervical squamous epithelium. Jeffers MD; Richmond J; Farquharson M; McNicol AM J Clin Pathol; 1994 Dec; 47(12):1073-6. PubMed ID: 7876377 [TBL] [Abstract][Full Text] [Related]
5. Detection of p53 protein and Ki-67 proliferation antigen in human papillomavirus (HPV)-positive and HPV-negative cervical lesions by immunohistochemical double-staining. Tervahauta AI; Syrjänen SM; Mäntyjärvi R; Syrjänen KJ Cytopathology; 1994 Oct; 5(5):282-93. PubMed ID: 7819513 [TBL] [Abstract][Full Text] [Related]
6. Correlation between human papillomavirus positivity and p53 gene overexpression in adenocarcinoma of the uterine cervix. Uchiyama M; Iwasaka T; Matsuo N; Hachisuga T; Mori M; Sugimori H Gynecol Oncol; 1997 Apr; 65(1):23-9. PubMed ID: 9103386 [TBL] [Abstract][Full Text] [Related]
7. Predictive significance of the alterations of p16INK4A, p14ARF, p53, and proliferating cell nuclear antigen expression in the progression of cervical cancer. Wang JL; Zheng BY; Li XD; Angström T; Lindström MS; Wallin KL Clin Cancer Res; 2004 Apr; 10(7):2407-14. PubMed ID: 15073118 [TBL] [Abstract][Full Text] [Related]
8. p53, retinoblastoma gene product, and cyclin protein expression in human papillomavirus virus DNA-positive cervical intraepithelial neoplasia and invasive cancer. Amortegui AJ; Meyer MP; Elborne VL; Amin RM Mod Pathol; 1995 Dec; 8(9):907-12. PubMed ID: 8751330 [TBL] [Abstract][Full Text] [Related]
9. Cervical squamous dysplasias and carcinomas with immunodetectable p53 frequently contain HPV. Mittal KR; Lin O; Chan W; Goswami S; Demopoulos RI Gynecol Oncol; 1995 Sep; 58(3):289-94. PubMed ID: 7672694 [TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical analysis of estrogen receptors, progesterone receptors, Ki-67 antigen, and human papillomavirus DNA in normal and neoplastic epithelium of the uterine cervix. Konishi I; Fujii S; Nonogaki H; Nanbu Y; Iwai T; Mori T Cancer; 1991 Sep; 68(6):1340-50. PubMed ID: 1651807 [TBL] [Abstract][Full Text] [Related]
11. Localization of p53 protein and human papillomavirus in anogenital squamous lesions: immunohistochemical and in situ hybridization studies in benign, dysplastic, and malignant epithelia. Walts AE; Koeffler HP; Said JW Hum Pathol; 1993 Nov; 24(11):1238-42. PubMed ID: 8244324 [TBL] [Abstract][Full Text] [Related]
12. An immunohistochemical analysis of sex-steroid receptors, tumor suppressor gene p53 and Ki-67 in the normal and neoplastic uterine cervix squamous epithelium. Nikolaou M; Koumoundourou D; Ravazoula P; Papadopoulou M; Michail G; Decavalas G Med Pregl; 2014; 67(7-8):202-7. PubMed ID: 25151759 [TBL] [Abstract][Full Text] [Related]
13. Detection of human papillomavirus DNA and expression of p16, Rb, and p53 proteins in small cell carcinomas of the uterine cervix. Wang HL; Lu DW Am J Surg Pathol; 2004 Jul; 28(7):901-8. PubMed ID: 15223960 [TBL] [Abstract][Full Text] [Related]
14. Altered expression of mdm-2 and its association with p53 protein status, tumor-cell-proliferation rate and prognosis in cervical neoplasia. Dellas A; Schultheiss E; Almendral AC; Gudat F; Oberholzer M; Feichter G; Moch H; Torhorst J Int J Cancer; 1997 Aug; 74(4):421-5. PubMed ID: 9291432 [TBL] [Abstract][Full Text] [Related]
15. An immunohistochemical study of p53 protein in cervical intraepithelial neoplasia and squamous cell carcinoma. Raju GC; Teh M; Wee A Pathology; 1996 Jan; 28(1):17-19. PubMed ID: 8714263 [TBL] [Abstract][Full Text] [Related]
16. [Comparative study of HPV infection and proliferating cell nuclear antigen of uterine cervix]. Murakami T; Nagai N; Ota S; Ohama K Nihon Sanka Fujinka Gakkai Zasshi; 1993 Sep; 45(9):967-72. PubMed ID: 8103785 [TBL] [Abstract][Full Text] [Related]
17. Telomerase activity, MIB-1, PCNA, HPV 16 and p53 as diagnostic markers for cervical intraepithelial neoplasia. Herbsleb M; Knudsen UB; Orntoft TF; Bichel P; Norrild B; Knudsen A; Mogensen O APMIS; 2001 Sep; 109(9):607-17. PubMed ID: 11878714 [TBL] [Abstract][Full Text] [Related]
18. Detection of human papillomavirus DNA sequences in oral squamous cell carcinomas and their relation to p53 and proliferating cell nuclear antigen expression. Shindoh M; Chiba I; Yasuda M; Saito T; Funaoka K; Kohgo T; Amemiya A; Sawada Y; Fujinaga K Cancer; 1995 Nov; 76(9):1513-21. PubMed ID: 8635051 [TBL] [Abstract][Full Text] [Related]